Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.

Published byЯна Бергер Modified over 5 years ago

Similar presentations

Presentation on theme: "Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive."— Presentation transcript:

1 Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive BioMedicine Online  Volume 39, Issue 2, Pages (August 2019) DOI: /j.rbmo Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

2 Figure 1 Organization of a conventional ovarian stimulation (OS) protocol with gonadotrophin-releasing hormone (GnRH) antagonist versus a progestin-primed ovarian stimulation (PPOS) protocol. HCG, human chorionic gonadotrophin. Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

Download ppt "Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive."

Similar presentations

Batuhan Ozmen, Murat Sönmezer, Cem Somer Atabekoglu, Hülya Olmuş 

Batuhan Ozmen, Murat Sönmezer, Cem Somer Atabekoglu, Hülya Olmuş 
Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Programmes and prospects for ovotechnology

Programmes and prospects for ovotechnology
Modified natural cycle IVF and mild IVF: a 10 year Swedish experience

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.

Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C

Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial  Eman A. Elgindy, Ahmed.

Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial  Eman A. Elgindy, Ahmed.
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase  TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase  TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,
Hatem Abu Hashim  Reproductive BioMedicine Online 

Hatem Abu Hashim  Reproductive BioMedicine Online 
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.

Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C

Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C
Higher β-HCG concentrations and higher birthweights ensue from single vitrified embryo transfers  Kevin N. Keane, Kamarul Bahyah Mustafa, Peter Hinchliffe,

Higher β-HCG concentrations and higher birthweights ensue from single vitrified embryo transfers  Kevin N. Keane, Kamarul Bahyah Mustafa, Peter Hinchliffe,
A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf 

A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf 
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF  Bart C.J.M. Fauser, Michael.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF  Bart C.J.M. Fauser, Michael.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,

Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 

Similar presentations

Ads by Google